CheckMan Stock Market Overview

SAN FRANCISCO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Investors in Kyndryl Holdings, Inc. (NYSE: KD) saw the price of their shares fall nearly 57% during trading on February 9, 2026 after the company announced that it would not timely file its quarterly report for the quarter ended December 31, 2025 and that its CFO (David Wyshner) and General Counsel (Edward Sebold) departed effective immediately four days before. These developments and severe market reaction have prompted national shareholder rights law firm Hagens Berman to open an investigation into whether Kyndryl may have misled investors about the propriety of assurances that its financial statements have been prepared consistent with relevant accounting rules and that its disclosure controls were sufficient.

The Invesco DB US Dollar Index Bullish Fund ETF closely tracks the U.S. dollar index, offering liquid exposure to dollar movements. Gold and silver saw parabolic rallies in January 2026, followed by sharp corrections, highlighting the persistent inverse correlation with the dollar index. UUP fell 2.4% as the dollar index dropped to a four-year low, then rebounded 2.7% as precious metals corrected, demonstrating strong tracking performance.

BENSALEM, Pa., Feb. 9, 2026 /PRNewswire/ -- The Law Offices of Howard G.

Spot gold surges on weakest dollar since January 30. Wednesday's NFP report could force Fed's hand on rate cuts, sending gold through $5143.89 breakout level.

MINNEAPOLIS, MN, US, Feb. 09, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., including its wholly-owned subsidiary Petvivo Animal Health, Inc. (OTCQX: PETV; OTCID: PETVW), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Monday, February 16, 2026 at 5:00 p.m. Eastern time to discuss results for the fiscal third quarter ended December 31, 2025. The financial results will be issued in a press release prior to the call.

SAN FRANCISCO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- On December 11, 2025, investors in Rezolute, Inc. (NASDAQ: RZLT) saw the price of their shares crater as much as 90% during intraday trading after the company revealed the failure of its Phase 3 sunRIZE trial for ersodetug (“erso”). The company has billed this drug as a potential treatment for hypoglycemia caused by hyperinsulinism (“HI”).

Target said in an email to employees obtained by CNBC that it will invest more in store labor and cut about 500 other roles in distribution centers and in regional offices. The big-box retailer is trying to win back shoppers who have complained about sloppier stores, out-of-stock items and longer checkout lines.

KKR & Co. Inc. (KKR) Presents at UBS Financial Services Conference 2026 Transcript

An overload of customer requests has reportedly led Alibaba's AI chatbot to pause issuing coupons. The issue with the Chinese tech giant's Qwen chatbot has marred the company's campaign to promote the tool's abilities beyond answering questions, Reuters reported Monday (Feb. 9).

Alphabet is tapping the debt markets, looking to raise about $20 billion in a bond sale. CNBC's MacKenzie Sigalos has more details.